AVY vs WST · P/E 17, rev $8.76B vs P/E 35, rev $2.89B
Avery Dennison Corp (AVY) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Avery Dennison Corp (AVY) is a packaging & containers company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported AVY revenue for 2024-12-28 was $8.76B. Net income was $704.9M. Revenue was up 4.7% from 2023-12-30 to 2024-12-28. AVY currently screens at market cap $11.87B and trailing P/E 17.5.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
AVY currently screens at market cap $11.87B and trailing P/E 17.5. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the AVY and WST stock pages for the full models.
Not investment advice.